AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
66.25
-0.27 (-0.41%)
Dec 27, 2024, 2:39 PM EST - Market open
AstraZeneca Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AstraZeneca stock have an average target of 88.8, with a low estimate of 82 and a high estimate of 97. The average target predicts an increase of 34.04% from the current stock price of 66.25.
Analyst Consensus: Buy
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for AstraZeneca stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Nov 20, 2024 |
| Erste Group | Erste Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 11, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $95 | Strong Buy | Maintains | $90 → $95 | +43.40% | Aug 12, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $80 → $85 | Strong Buy | Maintains | $80 → $85 | +28.30% | May 30, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $97 | Strong Buy | Initiates | $97 | +46.42% | May 30, 2024 |
Financial Forecast
Revenue This Year
53.91B
from 45.81B
Increased by 17.69%
Revenue Next Year
58.20B
from 53.91B
Increased by 7.95%
EPS This Year
4.16
from 3.81
Increased by 9.23%
EPS Next Year
4.80
from 4.16
Increased by 15.25%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 56.1B | 62.7B | 69.8B | |||
| Avg | 53.9B | 58.2B | 61.7B | |||
| Low | 49.2B | 52.0B | 54.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 22.5% | 16.3% | 19.9% | |||
| Avg | 17.7% | 8.0% | 6.0% | |||
| Low | 7.4% | -3.5% | -5.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.45 | 5.58 | 6.59 | |||
| Avg | 4.16 | 4.80 | 5.32 | |||
| Low | 3.31 | 3.61 | 4.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 16.9% | 34.0% | 37.5% | |||
| Avg | 9.2% | 15.3% | 11.0% | |||
| Low | -13.1% | -13.2% | -15.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.